{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T08:45:26Z","timestamp":1793868326256,"version":"4.6.1"},"reference-count":154,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016714","name":"University of Sharjah","doi-asserted-by":"publisher","award":["2201110357"],"award-info":[{"award-number":["2201110357"]}],"id":[{"id":"10.13039\/100016714","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.lfs.2023.121541","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T11:28:29Z","timestamp":1677756509000},"page":"121541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Targeting aldehyde dehydrogenase enzymes in combination with chemotherapy and immunotherapy: An approach to tackle resistance in cancer cells"],"prefix":"10.1016","volume":"320","author":[{"given":"Salma A.","family":"Al-Shamma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana M.","family":"Zaher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatema","family":"Hersi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nour N.","family":"Abu Jayab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hany A.","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2023.121541_bb0005","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.aar6711","article-title":"CAR T cell immunotherapy for human cancer","volume":"359","author":"June","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.lfs.2023.121541_bb0010","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.4161\/21645515.2014.980686","article-title":"DNA vaccine for cancer immunotherapy","volume":"10","author":"Yang","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.lfs.2023.121541_bb0015","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00262-002-0352-9","article-title":"Monoclonal antibody drug immunoconjugates for targeted treatment of cancer","volume":"52","author":"Trail","year":"2003","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.lfs.2023.121541_bb0020","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.bcp.2013.02.017","article-title":"Molecular aspects of cancer cell resistance to chemotherapy","volume":"85","author":"Rebucci","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2023.121541_bb0025","first-page":"141","article-title":"Drug resistance and combating drug resistance in cancer","volume":"2","author":"Wang","year":"2019","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.lfs.2023.121541_bb0030","first-page":"122","article-title":"Structure and function of ABC transporters","volume":"22","author":"Linton","year":"2007","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.lfs.2023.121541_bb0035","doi-asserted-by":"crossref","first-page":"339","DOI":"10.15171\/apb.2017.041","article-title":"The different mechanisms of cancer drug resistance: a brief review","volume":"7","author":"Mansoori","year":"2017","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.lfs.2023.121541_bb0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2001-1326-2-3","article-title":"Mechanisms of chemoresistance in cancer stem cells","volume":"2","author":"Abdullah","year":"2013","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.lfs.2023.121541_bb0045","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/aps.2013.27","article-title":"Understanding and targeting cancer stem cells: therapeutic implications and challenges","volume":"34","author":"Chen","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.lfs.2023.121541_bb0050","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.4161\/cc.10.9.15486","article-title":"Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform","volume":"10","author":"Marcato","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.lfs.2023.121541_bb0055","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.biopha.2013.04.005","article-title":"The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance","volume":"67","author":"Januchowski","year":"2013","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2023.121541_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.psj.2022.101790","article-title":"Sex differences in alcohol dehydrogenase levels (ADH) and blood ethanol concentration (BEC) in japanese quail","volume":"101","author":"Eaton","year":"2022","journal-title":"Poult. Sci."},{"key":"10.1016\/j.lfs.2023.121541_bb0065","article-title":"Association study of alcohol dehydrogenase and aldehyde dehydrogenase polymorphism with Alzheimer disease in the Taiwanese population","volume":"15","author":"Wu","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.lfs.2023.121541_bb0070","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s12015-010-9208-4","article-title":"The role of human aldehyde dehydrogenase in normal and cancer stem cells","volume":"7","author":"Ma","year":"2011","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.lfs.2023.121541_bb0075","doi-asserted-by":"crossref","first-page":"518","DOI":"10.21037\/atm.2016.11.82","article-title":"Aldehyde dehydrogenases in cancer stem cells: potential as therapeutic targets","volume":"4","author":"Clark","year":"2016","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.lfs.2023.121541_bb0080","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.tips.2019.08.002","article-title":"Aldehyde dehydrogenase inhibitors for cancer therapeutics","volume":"40","author":"Dinavahi","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2023.121541_bb0085","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s42003-022-03311-1","article-title":"Structural and biochemical evidence that ATP inhibits the cancer biomarker human aldehyde dehydrogenase 1A3","volume":"5","author":"Castellvi","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.lfs.2023.121541_bb0090","doi-asserted-by":"crossref","first-page":"3904645","DOI":"10.1155\/2019\/3904645","article-title":"Aldehyde dehydrogenases: not just markers, but functional regulators of stem cells","volume":"2019","author":"Vassalli","year":"2019","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.lfs.2023.121541_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-2797(00)00211-8","article-title":"Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism","volume":"129","author":"Vasiliou","year":"2000","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.lfs.2023.121541_bb0100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/978-981-13-6260-6_2","article-title":"Environmental aldehyde sources and the health implications of exposure","volume":"1193","author":"Sinharoy","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.lfs.2023.121541_bb0105","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1517\/17425255.4.6.697","article-title":"Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily","volume":"4","author":"Marchitti","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.lfs.2023.121541_bb0110","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.cbi.2012.10.026","article-title":"Aldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cells","volume":"202","author":"Vasiliou","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.lfs.2023.121541_bb0115","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/03602532.2018.1555587","article-title":"Aldehyde toxicity and metabolism: the role of aldehyde dehydrogenases in detoxification, drug resistance and carcinogenesis","volume":"51","author":"Ahmed Laskar","year":"2019","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.lfs.2023.121541_bb0120","article-title":"Emerging roles of aldehyde dehydrogenase isoforms in anti-cancer therapy resistance","volume":"9","author":"Zanoni","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.lfs.2023.121541_bb0125","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3904645","article-title":"Aldehyde dehydrogenases: not just markers, but functional regulators of stem cells","volume":"2019","author":"Vassalli","year":"2019","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.lfs.2023.121541_bb0130","doi-asserted-by":"crossref","first-page":"39747","DOI":"10.1074\/jbc.M004987200","article-title":"Feedback inhibition of the retinaldehyde dehydrogenase gene ALDH1 by retinoic acid through retinoic acid receptor alpha and CCAAT\/enhancer-binding protein beta","volume":"275","author":"Elizondo","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2023.121541_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110120","article-title":"Aldehyde dehydrogenase 1A1 and 1A3 isoforms - mechanism of activation and regulation in cancer","volume":"87","author":"Poturnajova","year":"2021","journal-title":"Cell. Signal."},{"key":"10.1016\/j.lfs.2023.121541_bb0140","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1158\/0008-5472.CAN-14-1924","article-title":"Aldehyde dehydrogenase is regulated by beta-Catenin\/TCF and promotes radioresistance in prostate cancer progenitor cells","volume":"75","author":"Cojoc","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2023.121541_bb0145","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3389\/fonc.2020.01039","article-title":"ALDH(HIGH) population is regulated by the AKT\/beta-catenin pathway in a cervical cancer model","volume":"10","author":"Sarabia-Sanchez","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2023.121541_bb0150","doi-asserted-by":"crossref","first-page":"30892","DOI":"10.1074\/jbc.M113.477158","article-title":"MUC1-C oncoprotein activates ERK\u2013>C\/EBPbeta signaling and induction of aldehyde dehydrogenase 1A1 in breast cancer cells","volume":"288","author":"Alam","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2023.121541_bb0155","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.ajpath.2015.01.011","article-title":"Smad4 decreases the population of pancreatic cancer-initiating cells through transcriptional repression of ALDH1A1","volume":"185","author":"Hoshino","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2023.121541_bb0160","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.canlet.2014.08.030","article-title":"Transforming growth factor-beta1-induced epithelial-mesenchymal transition generates ALDH-positive cells with stem cell properties in cholangiocarcinoma","volume":"354","author":"Shuang","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2023.121541_bb0165","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/s41419-018-0903-4","article-title":"High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH\/NRF2 signaling","volume":"9","author":"Kim","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2023.121541_bb0170","doi-asserted-by":"crossref","first-page":"12637","DOI":"10.18632\/oncotarget.3703","article-title":"A STAT3-NFkB\/DDIT3\/CEBP\u03b2 axis modulates ALDH1A3 expression in chemoresistant cell subpopulations","volume":"6","author":"Canino","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2023.121541_bb0175","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/gutjnl-2014-307616","article-title":"A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras\/Mek\/Erk-induced hyperactive mTOR signalling","volume":"65","author":"Kong","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2023.121541_bb0180","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","article-title":"ALDH1 is a marker of Normal and malignant human mammary stem cells and a predictor of poor clinical outcome","volume":"1","author":"Ginestier","year":"2007","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.lfs.2023.121541_bb0185","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10565-018-9444-y","article-title":"Identification of cancer-type specific expression patterns for active aldehyde dehydrogenase (ALDH) isoforms in ALDEFLUOR assay","volume":"35","author":"Zhou","year":"2019","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.lfs.2023.121541_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108822","article-title":"Clinical implications of ALDH1A1 and ALDH1A3 mRNA expression in melanoma subtypes","volume":"314","author":"Samson","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.lfs.2023.121541_bb0195","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/modpathol.2016.226","article-title":"High ALDH1 expression correlates with better prognosis in tumorigenic malignant melanoma","volume":"30","author":"Taylor","year":"2017","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.lfs.2023.121541_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18102039","article-title":"Differential functional roles of ALDH1A1 and ALDH1A3 in mediating metastatic behavior and therapy resistance of human breast cancer cells","volume":"18","author":"Croker","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2023.121541_bb0205","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1186\/s12885-018-4758-y","article-title":"ALDH1A3 upregulation and spontaneous metastasis formation is associated with acquired chemoresistance in colorectal cancer cells","volume":"18","author":"Durinikova","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lfs.2023.121541_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205536","article-title":"ALDH1A1 expression is associated with poor differentiation, 'right-sidedness' and poor survival in human colorectal cancer","volume":"13","author":"van der Waals","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2023.121541_bb0215","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41416-020-0865-z","article-title":"Ascites-derived ALDH+CD44+ tumour cell subsets endow stemness, metastasis and metabolic switch via PDK4-mediated STAT3\/AKT\/NF-kappaB\/IL-8 signalling in ovarian cancer","volume":"123","author":"Jiang","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lfs.2023.121541_bb0220","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0304-3835(87)90070-X","article-title":"Changes in the pattern of aldehyde dehydrogenase activity in primary and metastatic adenocarcinomas of the human colon","volume":"34","author":"Marselos","year":"1987","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2023.121541_bb0225","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1111\/j.1582-4934.2008.00455.x","article-title":"High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability","volume":"13","author":"Croker","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lfs.2023.121541_bb0230","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/0008-5472.CAN-08-2741","article-title":"Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature","volume":"69","author":"Charafe-Jauffret","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2023.121541_bb0235","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.stemcr.2013.11.009","article-title":"Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts","volume":"2","author":"Liu","year":"2014","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.lfs.2023.121541_bb0240","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1158\/0008-5472.CAN-09-3806","article-title":"High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer","volume":"70","author":"van den Hoogen","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2023.121541_bb0245","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10585-011-9395-7","article-title":"The aldehyde dehydrogenase enzyme 7A1 is functionally involved in prostate cancer bone metastasis","volume":"28","author":"van den Hoogen","year":"2011","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.lfs.2023.121541_bb0250","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1158\/1535-7163.MCT-19-0461","article-title":"Identification of ALDH1A3 as a viable therapeutic target in breast cancer metastasis-initiating cells","volume":"19","author":"Yamashita","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.lfs.2023.121541_bb0255","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/jcla.20241","article-title":"Alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) activity in the sera of patients with liver cancer","volume":"22","author":"Jelski","year":"2008","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.lfs.2023.121541_bb0260","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10585-015-9755-9","article-title":"Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors","volume":"33","author":"Rodriguez-Torres","year":"2016","journal-title":"Clin. Exp. Metastasis."},{"key":"10.1016\/j.lfs.2023.121541_bb0265","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3390\/cells10051056","article-title":"Mechanisms of metabolic reprogramming in cancer cells supporting enhanced growth and proliferation","volume":"10","author":"Schiliro","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.lfs.2023.121541_bb0270","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2023.121541_bb0275","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.3390\/molecules25204831","article-title":"Targeting metabolism in cancer cells and the tumour microenvironment for cancer therapy","volume":"25","author":"Li","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2023.121541_bb0280","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.stemcr.2019.08.015","article-title":"ALDH-dependent glycolytic activation mediates stemness and paclitaxel resistance in patient-derived spheroid models of uterine endometrial cancer","volume":"13","author":"Mori","year":"2019","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.lfs.2023.121541_bb0285","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2016.103","article-title":"Aldehyde dehydrogenase is used by cancer cells for energy metabolism","volume":"48","author":"Kang","year":"2016","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.lfs.2023.121541_bb0290","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3389\/fonc.2020.00915","article-title":"ALDH1A3 accelerates pancreatic cancer metastasis by promoting glucose metabolism","volume":"10","author":"Nie","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2023.121541_bb0295","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11306-021-01864-6","article-title":"Metabolite profiling reveals a connection between aldehyde dehydrogenase 1A3 and GABA metabolism in breast cancer metastasis","volume":"18","author":"Dahn","year":"2022","journal-title":"Metabolomics"},{"key":"10.1016\/j.lfs.2023.121541_bb0300","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1186\/s12885-018-5061-7","article-title":"Metabolic control of PPAR activity by aldehyde dehydrogenase regulates invasive cell behavior and predicts survival in hepatocellular and renal clear cell carcinoma","volume":"18","author":"Andrejeva","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lfs.2023.121541_bb0305","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.biochi.2017.02.015","article-title":"Necroptosis: modules and molecular switches with therapeutic implications","volume":"137","author":"Arora","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.lfs.2023.121541_bb0310","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1159\/000461391","article-title":"The opening of ATP-sensitive K+ channels protects H9c2 cardiac cells against the high glucose-induced injury and inflammation by inhibiting the ROS-TLR4-necroptosis pathway","volume":"41","author":"Liang","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.lfs.2023.121541_bb0315","first-page":"2807","article-title":"Alterations in necroptosis during ALDH2mediated protection against high glucoseinduced H9c2 cardiac cell injury","volume":"18","author":"Fang","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.lfs.2023.121541_bb0320","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.freeradbiomed.2019.09.026","article-title":"Aldehyde dehydrogenase-2 activation by Alda-1 decreases necrosis and fibrosis after bile duct ligation in mice","volume":"145","author":"Wimborne","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2023.121541_bb0325","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1016\/j.celrep.2019.02.032","article-title":"A pan-ALDH1A inhibitor induces necroptosis in ovarian cancer stem-like cells","volume":"26","author":"Chefetz","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.lfs.2023.121541_bb0330","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.coi.2007.02.004","article-title":"Regulatory T cells and cancer","volume":"19","author":"Wang","year":"2007","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.lfs.2023.121541_bb0335","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/imm.12747","article-title":"Mesenteric lymph node CD11b(-) CD103(+) PD-L1(High) dendritic cells highly induce regulatory T cells","volume":"152","author":"Shiokawa","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.lfs.2023.121541_bb0340","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4049\/jimmunol.1500474","article-title":"Cutting edge: dual function of PPARgamma in CD11c+ cells ensures immune tolerance in the airways","volume":"195","author":"Khare","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2023.121541_bb0345","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/cr.2016.151","article-title":"Regulatory T cells in cancer immunotherapy","volume":"27","author":"Tanaka","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.lfs.2023.121541_bb0350","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/tan.12329","article-title":"Tumor antigen-specific CD4+ T cells in cancer immunity: from antigen identification to tumor prognosis and development of therapeutic strategies","volume":"83","author":"Protti","year":"2014","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.lfs.2023.121541_bb0355","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/imm.13016","article-title":"Aldehyde dehydrogenase in regulatory T-cell development, immunity and cancer","volume":"156","author":"Bazewicz","year":"2019","journal-title":"Immunology"},{"key":"10.1016\/j.lfs.2023.121541_bb0360","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.1158\/1078-0432.CCR-11-1111","article-title":"Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8(+) T cells","volume":"17","author":"Visus","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2023.121541_bb0365","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.3390\/cancers11121963","article-title":"ALDH3A1 overexpression in melanoma and lung tumors drives cancer stem cell expansion, impairing immune surveillance through enhanced PD-L1 output","volume":"11","author":"Terzuoli","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.lfs.2023.121541_bb0370","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.3262237","article-title":"Effects of cyclosporine a on T cell development and clonal deletion","volume":"241","author":"Jenkins","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.lfs.2023.121541_bb0375","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006960","article-title":"Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide","volume":"5","author":"Kanakry","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.lfs.2023.121541_bb0380","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1182\/blood-2009-09-245274","article-title":"Skin-draining lymph nodes contain dermis-derived CD103(-) dendritic cells that constitutively produce retinoic acid and induce Foxp3(+) regulatory T cells","volume":"115","author":"Guilliams","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2023.121541_bb0385","article-title":"Eosinophils from murine lamina propria induce differentiation of naive T cells into regulatory T cells via TGF-beta1 and retinoic acid","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2023.121541_bb0390","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev-immunol-020711-075021","article-title":"Lung dendritic cells in respiratory viral infection and asthma: from protection to immunopathology","volume":"30","author":"Lambrecht","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.lfs.2023.121541_bb0395","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s41936-019-0083-5","article-title":"Recent advances in radiotherapy and its associated side effects in cancer\u2014a review","volume":"80","author":"Mohan","year":"2019","journal-title":"Journal of Basic and Applied Zoology."},{"key":"10.1016\/j.lfs.2023.121541_bb0400","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051151","article-title":"Nanog signaling mediates radioresistance in ALDH-positive breast cancer cells","volume":"20","author":"Dehghan Harati","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2023.121541_bb0405","doi-asserted-by":"crossref","DOI":"10.3390\/cells10010083","article-title":"Keap1-Nrf2 pathway regulates ALDH and contributes to radioresistance in breast cancer stem cells","volume":"10","author":"Kamble","year":"2021","journal-title":"Cells."},{"key":"10.1016\/j.lfs.2023.121541_bb0410","doi-asserted-by":"crossref","first-page":"419","DOI":"10.31557\/APJCP.2022.23.2.419","article-title":"Association of ALDH1 with response to radiotherapy and its impact on survival in patients with advanced stage of head and neck squamous cell carcinoma (HNSCC)","volume":"23","author":"Dubey","year":"2022","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.lfs.2023.121541_bb0415","first-page":"444","article-title":"Chloral hydrate: is it still being used? Are there safer alternatives?","volume":"44","author":"Grissinger","year":"2019","journal-title":"P t."},{"key":"10.1016\/j.lfs.2023.121541_bb0420","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/1573406416666191227111106","article-title":"Chemical properties and therapeutic potential of citral, a monoterpene isolated from lemongrass","volume":"17","author":"Sharma","year":"2021","journal-title":"Med. Chem."},{"key":"10.1016\/j.lfs.2023.121541_bb0425","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1124\/pr.111.005538","article-title":"Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application","volume":"64","author":"Koppaka","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.lfs.2023.121541_bb0430","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/1574892814666190514104035","article-title":"Repurposing disulfiram as an anti-cancer agent: updated review on literature and patents","volume":"14","author":"Ekinci","year":"2019","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"10.1016\/j.lfs.2023.121541_bb0435","doi-asserted-by":"crossref","first-page":"6331630","DOI":"10.1155\/2021\/6331630","article-title":"Therapeutic potential of isoflavones with an emphasis on daidzein","volume":"2021","author":"Alshehri","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2023.121541_bb0440","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3109\/13880209.2013.832776","article-title":"Therapeutic potential of gossypol: an overview","volume":"52","author":"Keshmiri-Neghab","year":"2014","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.lfs.2023.121541_bb0445","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma","volume":"6","author":"Johnson","year":"2020","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.lfs.2023.121541_bb0450","first-page":"2742","article-title":"Mechanisms of resistance in head and neck cancer","volume":"10","author":"Picon","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.lfs.2023.121541_bb0455","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/hed.21315","article-title":"Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase","volume":"32","author":"Clay","year":"2010","journal-title":"Head Neck."},{"key":"10.1016\/j.lfs.2023.121541_bb0460","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bbrc.2009.05.048","article-title":"Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer","volume":"385","author":"Chen","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2023.121541_bb0465","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.3390\/curroncol28040241","article-title":"Discrimination of cancer stem cell markers ALDH1A1, BCL11B, BMI-1, and CD44 in different tissues of HNSCC patients","volume":"28","author":"Sharaf","year":"2021","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.lfs.2023.121541_bb0470","doi-asserted-by":"crossref","first-page":"52345","DOI":"10.18632\/oncotarget.17017","article-title":"Targeting aldehyde dehydrogenase activity in head and neck squamous cell carcinoma with a novel small molecule inhibitor","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2023.121541_bb0475","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3390\/cells10030517","article-title":"Disulfiram acts as a potent radio-chemo sensitizer in head and neck squamous cell carcinoma cell lines and transplanted xenografts","volume":"10","author":"Yao","year":"2021","journal-title":"Cells."},{"key":"10.1016\/j.lfs.2023.121541_bb0480","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s13304-016-0359-y","article-title":"Worldwide burden of colorectal cancer: a review","volume":"68","author":"Favoriti","year":"2016","journal-title":"Updat. Surg."},{"key":"10.1016\/j.lfs.2023.121541_bb0485","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.18203\/2320-6012.ijrms20174914","article-title":"Colorectal cancer: a review","volume":"5","author":"Granados-Romero","year":"2017","journal-title":"Int. J. Res. Med. Sci."},{"key":"10.1016\/j.lfs.2023.121541_bb0490","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bbrc.2011.01.002","article-title":"Aldehyde dehydrogenase 1B1 (ALDH1B1) is a potential biomarker for human colon cancer","volume":"405","author":"Chen","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2023.121541_bb0495","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/life13010197","article-title":"The concept of cancer stem cells: elaborating on ALDH1B1 as an emerging marker of cancer progression","volume":"13","author":"Tsochantaridis","year":"2023","journal-title":"Life."},{"key":"10.1016\/j.lfs.2023.121541_bb0500","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1186\/s12885-018-4572-6","article-title":"ALDH1A inhibition sensitizes colon cancer cells to chemotherapy","volume":"18","author":"Kozovska","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lfs.2023.121541_bb0505","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","article-title":"Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020","volume":"134","author":"Cao","year":"2021","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.lfs.2023.121541_bb0510","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11864-012-0184-6","article-title":"Chemotherapy-resistant metastatic breast cancer","volume":"13","author":"Marquette","year":"2012","journal-title":"Curr. Treat. Options in Oncol."},{"key":"10.1016\/j.lfs.2023.121541_bb0515","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.biocel.2011.12.020","article-title":"Breast cancer stem cells","volume":"44","author":"Velasco-Velazquez","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.lfs.2023.121541_bb0520","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10549-011-1692-y","article-title":"Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44(+) human breast cancer cells","volume":"133","author":"Croker","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.lfs.2023.121541_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108727","article-title":"Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines","volume":"113","author":"Yang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2023.121541_bb0530","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/mc.22758","article-title":"Eugenol potentiates cisplatin anti-cancer activity through inhibition of ALDH-positive breast cancer stem cells and the NF-kappaB signaling pathway","volume":"57","author":"Islam","year":"2018","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.lfs.2023.121541_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108865","article-title":"Inhibition of aldehyde dehydrogenase-1 and p-glycoprotein-mediated multidrug resistance by curcumin and vitamin D3 increases sensitivity to paclitaxel in breast cancer","volume":"315","author":"Attia","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.lfs.2023.121541_bb0540","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/bjc.2013.534","article-title":"Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells","volume":"109","author":"Liu","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lfs.2023.121541_bb0545","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lfs.2023.121541_bb0550","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3390\/cells11040650","article-title":"Recent advances in ovarian cancer: therapeutic strategies, potential biomarkers, and technological improvements","volume":"11","author":"Akter","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.lfs.2023.121541_bb0555","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1158\/1535-7163.MCT-10-0563","article-title":"Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer","volume":"9","author":"Landen","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.lfs.2023.121541_bb0560","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.biocel.2016.07.017","article-title":"Inhibition of ALDH1A1 activity decreases expression of drug transporters and reduces chemotherapy resistance in ovarian cancer cell lines","volume":"78","author":"Januchowski","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.lfs.2023.121541_bb0565","doi-asserted-by":"crossref","first-page":"8754","DOI":"10.1021\/acs.jmedchem.8b00930","article-title":"Structure-based optimization of a novel class of aldehyde dehydrogenase 1A (ALDH1A) subfamily-selective inhibitors as potential adjuncts to ovarian cancer chemotherapy","volume":"61","author":"Huddle","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2023.121541_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109371","article-title":"Inhibitory effect on ovarian cancer ALDH+ stem-like cells by disulfiram and copper treatment through ALDH and ROS modulation","volume":"118","author":"Guo","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2023.121541_bb0575","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.7150\/thno.51885","article-title":"Aldehyde dehydrogenase inhibitors promote DNA damage in ovarian cancer and synergize with ATM\/ATR inhibitors","volume":"11","author":"Grimley","year":"2021","journal-title":"Theranostics."},{"key":"10.1016\/j.lfs.2023.121541_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113060","article-title":"Development of 2,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of aldehyde dehydrogenase 1A (ALDH1A) as potential adjuncts to ovarian cancer chemotherapy","volume":"211","author":"Huddle","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.lfs.2023.121541_bb0585","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1158\/1535-7163.MCT-19-0242","article-title":"ALDH1A1 contributes to PARP inhibitor resistance via enhancing DNA repair in BRCA2(-\/-) ovarian cancer cells","volume":"19","author":"Liu","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.lfs.2023.121541_bb0590","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.3390\/curroncol29040229","article-title":"Blockade of ALDH in cisplatin-resistant ovarian cancer stem cells in vitro synergistically enhances chemotherapy-induced cell death","volume":"29","author":"Guo","year":"2022","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.lfs.2023.121541_bb0595","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1021\/acs.jmedchem.8b00270","article-title":"Discovery of orally bioavailable, quinoline-based aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with potent cellular activity","volume":"61","author":"Yang","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2023.121541_bb0600","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/scd.2008.0055","article-title":"ALDH1 as a functional marker of cancer stem and progenitor cells","volume":"18","author":"Douville","year":"2009","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.lfs.2023.121541_bb0605","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010277","article-title":"Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers","volume":"5","author":"Deng","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2023.121541_bb0610","doi-asserted-by":"crossref","first-page":"13856","DOI":"10.1038\/s41598-017-14364-2","article-title":"Unraveling the roles of CD44\/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2023.121541_bb0615","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1136\/gutjnl-2012-303261","article-title":"Label-retaining liver cancer cells are relatively resistant to sorafenib","volume":"62","author":"Xin","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2023.121541_bb0620","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41420-021-00561-6","article-title":"3-hydroxyanthranic acid increases the sensitivity of hepatocellular carcinoma to sorafenib by decreasing tumor cell stemness","volume":"7","author":"Gan","year":"2021","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.lfs.2023.121541_bb0625","article-title":"Improving the therapeutic efficacy of sorafenib for hepatocellular carcinoma by repurposing disulfiram","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2023.121541_bb0630","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.tiv.2018.04.010","article-title":"Ovatodiolide suppresses yes-associated protein 1-modulated cancer stem cell phenotypes in highly malignant hepatocellular carcinoma and sensitizes cancer cells to chemotherapy in vitro","volume":"51","author":"Chang","year":"2018","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.lfs.2023.121541_bb0635","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3109\/07357907.2015.1034869","article-title":"Differential expression of cancer stem cell markers ALDH1 and CD133 in various lung cancer subtypes","volume":"33","author":"Roudi","year":"2015","journal-title":"Cancer Investig."},{"key":"10.1016\/j.lfs.2023.121541_bb0640","doi-asserted-by":"crossref","first-page":"1026278","DOI":"10.3389\/fonc.2022.1026278","article-title":"ALDH1: a potential therapeutic target for cancer stem cells in solid tumors","volume":"12","author":"Wei","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2023.121541_bb0645","doi-asserted-by":"crossref","first-page":"49397","DOI":"10.18632\/oncotarget.10354","article-title":"Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion","volume":"7","author":"Kang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2023.121541_bb0650","doi-asserted-by":"crossref","first-page":"611","DOI":"10.4155\/tde-2020-0130","article-title":"Inhibition of aldehyde dehydrogenase by furazolidone nanoemulsion to decrease cisplatin resistance in lung cancer cells","volume":"12","author":"Darooee","year":"2021","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.lfs.2023.121541_bb0655","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.bbrc.2014.03.047","article-title":"Inhibitory effect of disulfiram\/copper complex on non-small cell lung cancer cells","volume":"446","author":"Duan","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2023.121541_bb0660","doi-asserted-by":"crossref","first-page":"e00307","DOI":"10.1128\/MCB.00307-19","article-title":"The SOX9-aldehyde dehydrogenase Axis determines resistance to chemotherapy in non-small-cell lung cancer","volume":"40","author":"Voronkova","year":"2020","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2023.121541_bb0665","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s12185-017-2221-5","article-title":"Leukemic stem cells: identification and clinical application","volume":"105","author":"Hanekamp","year":"2017","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.lfs.2023.121541_bb0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2020.106351","article-title":"Disulfiram\/cytarabine eradicates a subset of acute myeloid leukemia stem cells with high aldehyde dehydrogenase expression","volume":"92","author":"Yang","year":"2020","journal-title":"Leuk. Res."},{"key":"10.1016\/j.lfs.2023.121541_bb0675","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3892\/ijo.2012.1516","article-title":"Aldehyde dehydrogenase 1A1 confers intrinsic and acquired resistance to gemcitabine in human pancreatic adenocarcinoma MIA PaCa-2 cells","volume":"41","author":"Duong","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.lfs.2023.121541_bb0680","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3892\/etm.2020.8691","article-title":"N, N-diethylaminobenzaldehyde targets aldehyde dehydrogenase to eradicate human pancreatic cancer cells","volume":"20","author":"Wang","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.lfs.2023.121541_bb0685","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1158\/1538-7445.AM2016-3350","article-title":"Abstract 3350: verification of mechanism that CSC markers are implicated in poor prognosis for pancreatic ductal adenocarcinoma","volume":"76","author":"Arima","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2023.121541_bb0690","article-title":"Reversing the intractable nature of pancreatic cancer by selectively targeting ALDH-high, therapy-resistant cancer cells","volume":"8","author":"Kim","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2023.121541_bb0695","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1002\/stem.1193","article-title":"ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets","volume":"30","author":"Luo","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.lfs.2023.121541_bb0700","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/CMR.0000000000000144","article-title":"Targeting ALDH1 to decrease tumorigenicity, growth and metastasis of human melanoma","volume":"25","author":"Yue","year":"2015","journal-title":"Melanoma Res."},{"key":"10.1016\/j.lfs.2023.121541_bb0705","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12964-021-00809-9","article-title":"Circular RNAs and glioblastoma multiforme: focus on molecular mechanisms","volume":"20","author":"Salami","year":"2022","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.lfs.2023.121541_bb0710","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/bjc.2012.442","article-title":"Cytotoxic effect of disulfiram\/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells","volume":"107","author":"Liu","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lfs.2023.121541_bb0715","doi-asserted-by":"crossref","first-page":"10496","DOI":"10.3390\/ijms221910496","article-title":"Disulfiram sensitizes a therapeutic-resistant glioblastoma to the TGF-beta receptor inhibitor","volume":"22","author":"Liu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2023.121541_bb0720","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrclinonc.2015.222","article-title":"Patient-reported outcomes in the evaluation of toxicity of anticancer treatments","volume":"13","author":"Di Maio","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.lfs.2023.121541_bb0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101405","article-title":"Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response","volume":"20","author":"Rupp","year":"2022","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.lfs.2023.121541_bb0730","doi-asserted-by":"crossref","DOI":"10.3332\/ecancer.2019.890","article-title":"Anticancer response to disulfiram may be enhanced by co-treatment with MEK inhibitor or oxaliplatin: modulation by tetrathiomolybdate, KRAS\/BRAF mutations and c-MYC\/p53 status","volume":"13","author":"Calderon-Aparicio","year":"2019","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.lfs.2023.121541_bb0735","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.734853","article-title":"Disulfiram improves the anti-PD-1 therapy efficacy by regulating PD-L1 expression via epigenetically reactivation of IRF7 in triple negative breast cancer","volume":"11","author":"Zheng","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2023.121541_bb0740","first-page":"2442","article-title":"Disulfiram combined with copper induces immunosuppression via PD-L1 stabilization in hepatocellular carcinoma","volume":"9","author":"Zhou","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.lfs.2023.121541_bb0745","doi-asserted-by":"crossref","first-page":"16168","DOI":"10.1038\/s41598-019-52507-9","article-title":"The biological activity of bispecific trastuzumab\/pertuzumab plant biosimilars may be drastically boosted by disulfiram increasing formaldehyde accumulation in cancer cells","volume":"9","author":"Komarova","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2023.121541_bb0750","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1039\/C7SC04853J","article-title":"Dual-targeting biomimetic delivery for anti-glioma activity via remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy","volume":"9","author":"Zhao","year":"2018","journal-title":"Chem. Sci."},{"key":"10.1016\/j.lfs.2023.121541_bb0755","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nrd4253","article-title":"Tackling the cancer stem cells - what challenges do they pose?","volume":"13","author":"Pattabiraman","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.lfs.2023.121541_bb0760","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1158\/0008-5472.CAN-11-1400","article-title":"Cancer stem cell vaccination confers significant antitumor immunity","volume":"72","author":"Ning","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2023.121541_bb0765","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1158\/0008-5472.CAN-12-3349","article-title":"HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: implications for efficacy of adjuvant trastuzumab","volume":"73","author":"Ithimakin","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2023.121541_bb0770","doi-asserted-by":"crossref","DOI":"10.4161\/2162402X.2014.990767","article-title":"Cancer stem cell vaccine inhibits metastases of primary tumors and induces humoral immune responses against cancer stem cells","volume":"4","author":"Lu","year":"2015","journal-title":"Oncoimmunology"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523001753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523001753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:09:32Z","timestamp":1758402572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320523001753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":154,"alternative-id":["S0024320523001753"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121541","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting aldehyde dehydrogenase enzymes in combination with chemotherapy and immunotherapy: An approach to tackle resistance in cancer cells","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121541","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121541"}}